Incidence of cytomegalovirus infection in Shanghai, China

Clinical and Vaccine Immunology

Volumn 16, Issue 11, 2009, Pages 1700-1703

  Fang, Feng Qin ^a   Fan, Qi Shi ^a   Yang, Zhi Jun ^b   Peng, Yi Bing ^a   Zhang, Li ^a   Mao, Ke Zi ^a   Zhang, Yue ^a   Ji, Yu Hua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Fosun Med Tech Development Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CATALYSIS; CHILD; CHINA; CYTOMEGALOVIRUS INFECTION; FEMALE; GROUPS BY AGE; HUMAN; INCIDENCE; INFANT; MALE; PRIORITY JOURNAL; REPRODUCTION; SEROLOGY; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BASIC REPRODUCTION NUMBER; CHILD, PRESCHOOL; CHINA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREGNANCY; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 70350702933     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00385-08     Document Type: Article

References (23)

1. Adler, S. P., and B. Marshall. 2007. Cytomegalovirus infections. Pediatr. Rev. 28:92-100.
2. + T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J. Virol. 79:3675-3683.
3. Almeidaa, L. N., R. S. Azevedoa, M. Amakub, and E. Massad. 2001. Cytomegalovirus seroepidemiology in an urban community of São Paulo, Brazil. Rev. Saude Publica 35:124-129.
4. Boppana, S. B., L. B. Rivera, K. B. Fowler, M. Mach, and W. J. Britt. 2001. Intrauterine transmission of cytomegalovirus to infants of women with pre-conceptional immunity. N. Engl. J. Med. 344:1366-1371.
5. Chen, C. Z., and J. Z. Bu. 2007. The investigation of inflection of TORCH in neonate. Matern. Child Health Care China 22:3099-3100. (In Chinese.)
6. Colugnati, F. A., S. A. Staras, S. C. Dollard, and M. J. Cannon. 2007. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect. Dis. 7:71-80.
7. de Ory, F., R. Ramírez, L. García Comas, P. León, M. J. Sagües, and J. C. Sanz. 2004. Is there a change in cytomegalovirus seroepidemiology in Spain? Eur. J. Epidemiol. 19:85-89.
8. Farrington, C. P. 1990. Modelling forces of infection for measles, mumps and rubella. Stat. Med. 9:953-967.
9. Gaytant, M. A., J. M. Galama, B. A. Semmekrot, W. J. Melchers, J. M. Sporken, H. P. Oosterbaan, P. A. van Dop, A. Huisman, H. M. Merkus, and E. A. Steegers. 2005. The incidence of congenital cytomegalovirus infections in The Netherlands. J. Med. Virol. 76:71-75.
10. Griffiths, P. D., A. McLean, and V. C. Emery. 2001. Encouraging prospects for immunisation against primary cytomegalovirus infection. Vaccine 19:1356-1362.
11. Kenneson, A., and M. J. Cannon. 2007. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol. 17:253-276.
12. Koch, S., R. Solana, O. Dela Rosa, and G. Pawelec. 2006. Human cytomegalovirus infection and T cell immunosenescence: a mini review. Mech. Ageing Dev. 127:538-543.
13. Li, K. H., H. Liu, J. Y. Liu, and Y. J. Li. 2003. Analysis of serological findings and clinical manifestations of TORCH infections in newborns. Chin. J. Exp. Clin. Virol. 17:283-284. (In Chinese.)
14. Li, W. C., D. T. Zhao, Q. B. Zhao, L. C. Wang, and H. Zhang. 2007. The choice and calculation of force of infection in regression of catalytic model. J. Math. Med. 20:135-136. (In Chinese.)
15. Pawelec, G., and C. Gouttefangeas. 2006. T-cell dysregulation caused by chronic antigenic stress: the role of CMV in immunosenescence? Aging Clin. Exp. Res. 18:171-173.
16. Ping, Y. 2007. The status and treatment of CMV infection in newborns. Shanghai Med. Pharm. J. 28:224-226. (In Chinese.)
17. Rawlinson, W., and G. Scott. 2003. Cytomegalovirus: a common virus causing serious disease. Aust. Fam. Physician 32:789-793.
18. Schleiss, M. R., and T. C. Heineman. 2005. Progress toward an elusive goal: current status of cytomegalovirus vaccines. Expert Rev. Vaccin. 4:381-406.
19. Seale, H., C. R. MacIntyre, H. F. Gidding, J. L. Backhouse, D. E. Dwyer, and L. Gilbert. 2006. National serosurvey of cytomegalovirus in Australia. Clin. Vaccine Immunol. 13:1181-1184.
20. Stassen, F. R., T. Vainas, and C. A. Bruggeman. 2008. Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol. Rep. 60:85-92.
21. Streblow, D. N., J. Dumortier, A. V. Moses, S. L. Orloff, and J. A. Nelson. 2008. Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr. Top. Microbiol. Immunol. 325:397-415.
22. Zhong, J., and R. Khanna. 2007. Vaccine strategies against human cytomegalovirus infection. Expert Rev. Anti-Infect. Ther. 5:449-459.
23. Zhou, P., L. Yao, and S. F. Wang. 2004. Research on the status of CMV infection in the pregnant and newborns. J. Harbin Med. Univ. 38:393-395. (In Chinese.)